The Leadership Team at PepGen is responsible for strategic decision-making and overseeing the company's vision to develop innovative therapeutics targeting genetic diseases. Comprising experts from various disciplines including clinical science, research, toxicology, and manufacturing, this team drives the pipeline of disease-modifying therapies, ensuring alignment with the company's mission and effective project execution. Their collaborative efforts are essential for guiding PepGen through clinical advancements and maintaining regulatory compliance, ultimately aiming to improve patient outcomes in neuromuscular diseases.